Skip to main content
News Icon

News categories: Honors & Funding

Collaborative research center being renewed

German Research Foundation funds CRC "Synaptic Micronetworks in Health and Disease" for another four years

The mammalian brain is extraordinarily complex - it is estimated to consist of around 100 billion nerve cells. Each of these cells is linked via synapses to tens of thousands of other brain cells. How do the elements of such a complex network work together to produce behavior? How do the networks change as a result of disease? For eight years, scientists have been investigating these and other questions in the Collaborative Research Center (CRC) 1089 "Synaptic Micronetworks in Health and Disease" at the University of Bonn. With great success: The German Research Foundation (DFG) is funding the interdisciplinary network for another four years. The requested funding amount is around 11.1 million euros. Partners are the caesar research center in the Max Planck Society and the German Center for Neurodegenerative Diseases in Bonn. Member of the Cluster of Excellence ImmunoSensation2 Prof. Heinz Beck is spokesperson of the recently renewed CRC.

At the most elementary level, the researchers want to investigate the properties of individual synapses - the contact points between nerve cells. They also want to investigate how these connections between brain cells are affected by diseases in their structure and function. At the next level up, the scientists want to find out how the many tens of thousands of synaptic input signals that arrive at cell processes of the nerve cells, so-called dendrites, are processed. Here, too, the focus is on epilepsy and Alzheimer's disease. At the level of neuronal networks, the researchers are interested in understanding the interplay between different types of nerve cells in the development of normal and pathologically disturbed behavior. To achieve these goals, mathematical and theoretical methods will be increasingly applied in the third funding period.

The researchers in the interdisciplinary CRC 1089 aim to make a significant contribution to a better understanding of how the brain works. However, a particular goal is also to investigate brain dysfunction in two of the most common neurological diseases: Epilepsy and Alzheimer's disease. The speaker of the Collaborative Research Center is the neuroscientist Prof. Dr. Heinz Beck, head of the Institute for Experimental Epileptology and Cognition Research at the University and the University Hospital of Bonn and a member of the ImmunoSensation2 Cluster of Excellence. Vice speaker is the biochemist Prof. Dr. Susanne Schoch McGovern from the Institute of Neuropathology at the University of Bonn.


Contact

Prof. Dr. Heinz Beck

Institute for Experimental Epileptology and Cognitive Research

University of Bonn

University Hospital Bonn

Phone: +49 228 6885270

Email: Heinz.Beck@ukb.uni-bonn.de

Prof. Dr. Susanne Schoch McGovern

Institute of Neuropathology, University of Bonn

University Hospital Bonn

Phone: +49 228 28719109

Email: susanne.schoch@uni-bonn.de

Related news

Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry

Back to the news overview